Trademarkia Logo

Canada

C$
PROGENTOS THERAPEUTICS
FORMALIZED

on 16 Oct 2024

Last Applicant/ Owned by

Progentos Therapeutics, Inc.

200 Dexter AveWatertown MA 02472

US

Serial Number

2356248 filed on 12th Aug 2024

PROGENTOS THERAPEUTICS

Trademark usage description

pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central Read More

Classification Information


Class [005]
Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders.


Classification kind code

12

Class [042]
Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders.


Classification kind code

12

Mark Details


Serial Number

2356248

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 17th Oct 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 16th Oct 2024
Created
Submitted for opposition 31
on 16th Oct 2024
Formalized
Submitted for opposition 228
on 12th Aug 2024
International Registration
Submitted for opposition 30
on 12th Aug 2024
Filed